Q2 2021 Ultragenyx Pharmaceutical Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the second quarter 2021 financial results and corporate update conference call. (Operator Instructions) I would now like to hand the conference over to your first speaker today, Joshua Higa, Director of Investor Relations. Thank you. Please go ahead.
Good afternoon, and welcome to the Ultragenyx financial results and corporate update conference Call for the second quarter 2021. We have issued a press release detailing our financial results, which you can find on our website at ultragenyx.com. I am Joshua Higa, Director of Investor Relations. Joining me on this call are Emil Kakkis, Chief Executive Officer and President; Camille Bedrosian, Chief Medical Officer; and Erik Harris, Chief Commercial Officer. Mardi Dier, our Chief Financial Officer, had an unavoidable flight delay and is not able to join us on today's call.
I would like to remind investors that this call will include forward-looking statements within
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
